Susquehanna International Group
ANAC

Susquehanna International Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Susquehanna International Group’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-191,500
Closed -$10.2M – 10169
2016
Q1 		$10.2M Sell
191,500
-2,700
-1% -$199K 0.01% 1538
2015
Q4 		$21.9M Buy
194,200
+101,900
+110% +$11.2M 0.01% 1067
2015
Q3 		$10.9M Sell
92,300
-175,300
-66% -$22.9M ﹤0.01% 1747
2015
Q2 		$20.7M Buy
267,600
+124,400
+87% +$8.16M 0.01% 1273
2015
Q1 		$8.28M Sell
143,200
-6,200
-4% -$263K ﹤0.01% 2079
2014
Q4 		$4.82M Buy
149,400
+45,900
+44% +$1.38M ﹤0.01% 2944
2014
Q3 		$2.53M Buy
103,500
+40,600
+65% +$825K ﹤0.01% 4199
2014
Q2 		$1.12M Buy
62,900
+19,300
+44% +$311K ﹤0.01% 5811
2014
Q1 		$872K Buy
43,600
+26,400
+153% +$512K ﹤0.01% 5752
2013
Q4 		$289K Buy
+17,200
New +$238K ﹤0.01% 7646
2013
Q3 		– Sell
-20,700
Closed -$116K – 9299
2013
Q2 		$116K Buy
+20,700
New +$125K ﹤0.01% 7733

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Susquehanna International Group's ANAC Position: Q2 2016 in Review

Susquehanna International Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 101,038 shares — an estimated $5.4M sold.

Susquehanna International Group first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $37.3M in Q2 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Susquehanna International Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Susquehanna International Group sold 101,038 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.4M.
  • Susquehanna International Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • Susquehanna International Group's ANACOR PHARMACEUTICALS INC COM position peaked at $37.3M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Susquehanna International Group's 13F filing for Q2 2016, filed 15 Aug 2016.